The Maya Handler Fellow
Charles Keller
August 14, 2025
To Donate to this cause, please click here Throughout Maya’s brave journey, our family found both hope and guidance in cc-TDI’s work, making this cause
Re-invest in Research
Charles Keller
April 28, 2025
This year marks 10 years of innovation and progress at cc-TDI, and we’re proud to reflect on the milestone we’ve reached—because of you. Despite a
10 Year Impact Report!
Charles Keller
April 23, 2025
We’re celebrating 10 years of impact at cc-TDI! Thanks to your partnership, we’ve translated two drugs into three national and international clinical trials, published 68
cc-TDI Partners with NIH on RMS
admin
January 16, 2025
The Children’s Cancer Therapy Development Institute (cc-TDI) is proud to announce a new publication, DNA methylation patterns are influenced by Pax3::Foxo1 expression and developmental lineage
Our hero, Abby: A Parent’s Heartfelt Journey
admin
December 1, 2024
This holiday season, we recognize the promise that our research holds for childhood cancer heroes and their families. And at cc-TDI, the parent partnership is
2025 Summer Internship Opportunities!
Charles Keller
November 16, 2024
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
Megan’s Mission Awards $222,120 in RMS Support
admin
September 30, 2024
The Children’s Cancer Therapy Development Institute (cc-TDI) has been awarded $222,120 by the Megan’s Mission Foundation to advance three clinical research initiatives focused on Rhabdomyosarcoma
Sharing our Why: Science-Justified Hope
admin
September 3, 2024
This month, we invite you to join us in supporting pioneering research at cc-TDI, which has served as a beacon of hope for families like ours. Our
Entinostat as a combinatorial therapeutic for RMS
Charles Keller
August 18, 2024
In a groundbreaking study, Entinostat as a combinatorial therapeutic for rhabdomyosarcoma, published earlier this week in Scientific Reports, researchers with the Children’s Cancer Therapy Development
Claire Newman appointed new Executive Director
Charles Keller
July 13, 2024
The Children’s Cancer Therapy Development Institute (cc-TDI) is delighted to welcome former Intel Executive, Claire Newman, as their new Executive Director on July 1st. Claire
Celebrating Billy’s Legacy: The 7th Annual Hundt Strong Golf Outing
admin
June 30, 2024
The Hundt Strong golf outing began in 2017 as a way to support Billy Hundt during his extensive treatment for rhabdomyosarcoma (RMS). From that very
cc-TDI Celebrates First Year
admin
May 21, 2024
On Monday, May 13th, joined by dear supporters and friends, cc-TDI virtually celebrated the one-year anniversary of our new laboratory. Thanks to incredible support over
Inspired Through Love
Charles Keller
May 8, 2024
In March the Children’s Cancer Therapy Development Institute (cc-TDI) announced its partnership with Team KOODAC (Knock Out Oncogenic Drivers and Curing Childhood Cancer), a global
cc-TDI’s 2023 Impact Report
Charles Keller
May 7, 2024
We are thrilled to present the 2023 inaugural Impact Report for the Children’s Cancer Therapy Development Institute (cc-TDI), a testament to our joint commitment to advancing childhood
cc-TDI Collaborates Globally with Atomwise
admin
April 5, 2024
We proudly announce our global Artificial Intelligence (AI) collaboration with Atomwise, resulting in a new publication in the journal Scientific Reports. The paper, “AI is
State of Oregon Awards $1M in Equipment
Charles Keller
March 15, 2024
In a significant stride towards advancing pediatric cancer research, we are thrilled to announce that the state of Oregon has allocated a generous $1 million
cc-TDI joins global Cancer Grand Challenges team taking on solid tumors in children
admin
March 6, 2024
The Children’s Cancer Therapy Development Institute (cc-TDI) proudly announces its partnership with Team KOODAC (Knock Out Oncogenic Drivers and Curing Childhood Cancer), a global interdisciplinary
Entinostat Moving Forward
admin
February 29, 2024
We are excited to update you on entinostat, a therapy that’s traveled through cc-TDI’s development pipeline in the fight against rhabdomyosarcoma (RMS). Entinostat is a breast
Apply Now – Postdoctoral Fellowship at cc-TDI
Charles Keller
February 5, 2024
Are you a PhD developmental biologist, biochemist, molecular biologist, biomedical engineer or stem cell biologist interested in changing paradigms and outcomes for cancers of children,
The Maya Handler Fellow
Charles Keller
August 14, 2025
To Donate to this cause, please click here Throughout Maya’s brave journey, our family found both hope and guidance in cc-TDI’s work, making this cause
Re-invest in Research
Charles Keller
April 28, 2025
This year marks 10 years of innovation and progress at cc-TDI, and we’re proud to reflect on the milestone we’ve reached—because of you. Despite a
10 Year Impact Report!
Charles Keller
April 23, 2025
We’re celebrating 10 years of impact at cc-TDI! Thanks to your partnership, we’ve translated two drugs into three national and international clinical trials, published 68
cc-TDI Partners with NIH on RMS
admin
January 16, 2025
The Children’s Cancer Therapy Development Institute (cc-TDI) is proud to announce a new publication, DNA methylation patterns are influenced by Pax3::Foxo1 expression and developmental lineage
Our hero, Abby: A Parent’s Heartfelt Journey
admin
December 1, 2024
This holiday season, we recognize the promise that our research holds for childhood cancer heroes and their families. And at cc-TDI, the parent partnership is
2025 Summer Internship Opportunities!
Charles Keller
November 16, 2024
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
Megan’s Mission Awards $222,120 in RMS Support
admin
September 30, 2024
The Children’s Cancer Therapy Development Institute (cc-TDI) has been awarded $222,120 by the Megan’s Mission Foundation to advance three clinical research initiatives focused on Rhabdomyosarcoma
Sharing our Why: Science-Justified Hope
admin
September 3, 2024
This month, we invite you to join us in supporting pioneering research at cc-TDI, which has served as a beacon of hope for families like ours. Our
Entinostat as a combinatorial therapeutic for RMS
Charles Keller
August 18, 2024
In a groundbreaking study, Entinostat as a combinatorial therapeutic for rhabdomyosarcoma, published earlier this week in Scientific Reports, researchers with the Children’s Cancer Therapy Development
Claire Newman appointed new Executive Director
Charles Keller
July 13, 2024
The Children’s Cancer Therapy Development Institute (cc-TDI) is delighted to welcome former Intel Executive, Claire Newman, as their new Executive Director on July 1st. Claire
Celebrating Billy’s Legacy: The 7th Annual Hundt Strong Golf Outing
admin
June 30, 2024
The Hundt Strong golf outing began in 2017 as a way to support Billy Hundt during his extensive treatment for rhabdomyosarcoma (RMS). From that very
cc-TDI Celebrates First Year
admin
May 21, 2024
On Monday, May 13th, joined by dear supporters and friends, cc-TDI virtually celebrated the one-year anniversary of our new laboratory. Thanks to incredible support over
Inspired Through Love
Charles Keller
May 8, 2024
In March the Children’s Cancer Therapy Development Institute (cc-TDI) announced its partnership with Team KOODAC (Knock Out Oncogenic Drivers and Curing Childhood Cancer), a global
cc-TDI’s 2023 Impact Report
Charles Keller
May 7, 2024
We are thrilled to present the 2023 inaugural Impact Report for the Children’s Cancer Therapy Development Institute (cc-TDI), a testament to our joint commitment to advancing childhood
cc-TDI Collaborates Globally with Atomwise
admin
April 5, 2024
We proudly announce our global Artificial Intelligence (AI) collaboration with Atomwise, resulting in a new publication in the journal Scientific Reports. The paper, “AI is
State of Oregon Awards $1M in Equipment
Charles Keller
March 15, 2024
In a significant stride towards advancing pediatric cancer research, we are thrilled to announce that the state of Oregon has allocated a generous $1 million
cc-TDI joins global Cancer Grand Challenges team taking on solid tumors in children
admin
March 6, 2024
The Children’s Cancer Therapy Development Institute (cc-TDI) proudly announces its partnership with Team KOODAC (Knock Out Oncogenic Drivers and Curing Childhood Cancer), a global interdisciplinary
Entinostat Moving Forward
admin
February 29, 2024
We are excited to update you on entinostat, a therapy that’s traveled through cc-TDI’s development pipeline in the fight against rhabdomyosarcoma (RMS). Entinostat is a breast
Apply Now – Postdoctoral Fellowship at cc-TDI
Charles Keller
February 5, 2024
Are you a PhD developmental biologist, biochemist, molecular biologist, biomedical engineer or stem cell biologist interested in changing paradigms and outcomes for cancers of children,
